China’s State Oceanic Administration (SOA) has announced in a report that the country’s overall marine product has increased by 6.8 percent year-on-year to over RMB 7 trillion in 2016, making up 9.5 percent of China’s GDP last year. Value-added marine produce accounted for 54 percent of the overall industry, reaching RMB 3.84 trillion last year.
Meanwhile, the marine biopharmaceutical industry made significant growth last year, and coastal tourism has also been steadily expanding.
The report notes a decline in output and added value of offshore oil and gas from 2015, with challenges remaining for China’s maritime shipping industry, despite efforts towards structural optimization. However, China has completed numerous maritime projects, including the installation of offshore wind farms.
Analysts have commented on how manufacturers can accomplish plans for premier Li Keqiang’s ‘Made in China 2025’ initiative, saying that they should put more emphasis on mastering core technologies in key sectors in order to improve R&D capabilities, while introducing advanced technologies and equipment from abroad. This will be done by strengthening corporate management, enhancing the quality of their products, as well as recruiting more R&D personnel.
At the same time, it has been stressed that Chinese enterprises should be able to learn and ‘absorb’ foreign expertise in order to bridge the quality gap. The Made in China 2025 initiative, which is designed to upgrade China’s manufacturing capability, aims for 40 percent of key equipment components and key infrastructure material to be produced in China by 2020, and 70 percent by 2025.
RELATED: Pre-Investment and Entry Strategy Advisory from Dezan Shira & Associates
Experts have said that online healthcare companies need to be in possession of key medical facilities like hospitals and doctors in order to maintain market competition. Such tangible medical resources are not only core assets for the industry, but are indispensable for the medical profession and cannot be replaced by internet technology.
The majority of online consultation and diagnoses are in need of further examination and treatment in physical hospitals, said Huo Yong, director of the Department of Cardiology and Heart Center at Peking University First Hospital. Since 2011, more than 1,000 online medical enterprises have come about in the field of medical consultation and biotechnology. However, most are still in their formative stage, experimenting with suitable business models, and exploring how to gain trust from doctors and patients alike.
China’s National Development and Reform Commission (NDRC) has announced a second cut to retail oil prices this year. Gas and diesel prices will be reduced by RMB 85 (US$12.3) per ton due to falling international prices. Due to crude oil reserves in the US and the stronger performance of the dollar, international prices have continued to decline.
China has a pricing regime in place which adjusts domestic oil prices when the international price of crude oil drops by RMB 50 per ton during a period of 10 working days. The NDRC price monitoring center has said that oil prices will be kept relatively low in the short term due weak demand.
Asia Briefing Ltd. is a subsidiary of Dezan Shira & Associates. Dezan Shira is a specialist foreign direct investment practice, providing corporate establishment, business advisory, tax advisory and compliance, accounting, payroll, due diligence and financial review services to multinationals investing in China, Hong Kong, India, Vietnam, Singapore and the rest of ASEAN. For further information, please email email@example.com or visit www.dezshira.com.
Stay up to date with the latest business and investment trends in Asia by subscribing to our complimentary update service featuring news, commentary and regulatory insight.
Dezan Shira & Associates Brochure
Dezan Shira & Associates is a pan-Asia, multi-disciplinary professional services firm, providing legal, tax and operational advisory to international corporate investors. Operational throughout China, ASEAN and India, our mission is to guide foreign companies through Asia’s complex regulatory environment and assist them with all aspects of establishing, maintaining and growing their business operations in the region. This brochure provides an overview of the services and expertise Dezan Shira & Associates can provide.
An Introduction to Doing Business in China 2017
Doing Business in China 2017 is designed to introduce the fundamentals of investing in China. Compiled by the professionals at Dezan Shira & Associates in January 2017, this comprehensive guide is ideal not only for businesses looking to enter the Chinese market, but also for companies who already have a presence here and want to keep up-to-date with the most recent and relevant policy changes.
New Considerations when Establishing a China WFOE in 2017
In this edition of China Briefing, we guide readers through a range of topics, from the reasons behind foreign investors’ preference for the WFOE as an investment model, to managing China’s new regulations. We discuss how economic transformations have favored the WFOE, as well as the investment model’s utility, and detail key requirements that businesspeople need to examine before initiating the WFOE setup process. We then walk investors through the WFOE establishment process, and, finally, explain the new and idiosyncratic “Actual Controlling Person” regulation.
Previous Article « Asia Investment Brief: IPOs in India, Manufacturing Locations in Indonesia, and Foreign Trademarks in Russia
Next Article Asia Investment Brief: Trade Mark Rules in India, Setting Up an RO in Russia, and Agriculture in Vietnam »
Dezan Shira & Associates´ brochure offers a comprehensive overview of the services provided by the firm. With its team of lawyers, tax experts, auditors and...
A firm understanding of China’s laws and regulations related to human resources and payroll management is absolutely necessary for foreign businesses in...
Doing Business in China 2022 is designed to introduce the fundamentals of investing in China. Compiled by the professionals at Dezan Shira & Associates in...
With the scope and penalties of China’s social credit system being further clarified in 2021, legal and regulatory compliance has become more important than...
As a legitimate tool for reasonable tax planning and cost saving, tax incentives play an important role. Companies also use tax incentives as a useful...
Over the last few months, China has been quickly expanding the pilot program on electronic special value-added tax (VAT) fapiao (hereafter special VAT...
Dezan Shira & Associates helps
businesses establish, maintain,
and grow their operations.
Stay Ahead of the curve in Emerging Asia. Our subscription service offers regular regulatory updates,
including the most recent legal, tax and accounting changes that affect your business.